IDEX Biometrics ASA (NASDAQ:IDBA) Expected to Announce Quarterly Sales of $1.70 Million

Wall Street analysts expect IDEX Biometrics ASA (NASDAQ:IDBAGet Rating) to report sales of $1.70 million for the current quarter, Zacks reports. Two analysts have made estimates for IDEX Biometrics ASA’s earnings. The lowest sales estimate is $900,000.00 and the highest is $2.50 million. IDEX Biometrics ASA posted sales of $620,000.00 in the same quarter last year, which would indicate a positive year over year growth rate of 174.2%. The firm is expected to issue its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that IDEX Biometrics ASA will report full-year sales of $10.05 million for the current fiscal year, with estimates ranging from $7.10 million to $13.00 million. For the next year, analysts expect that the business will report sales of $43.50 million, with estimates ranging from $37.00 million to $50.00 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover IDEX Biometrics ASA.

IDEX Biometrics ASA (NASDAQ:IDBAGet Rating) last announced its quarterly earnings data on Thursday, February 24th. The company reported ($1.50) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.56) by ($0.94). The firm had revenue of $0.79 million for the quarter, compared to the consensus estimate of $0.82 million. IDEX Biometrics ASA had a negative return on equity of 115.40% and a negative net margin of 1,146.20%.

Shares of NASDAQ:IDBA opened at $14.35 on Friday. The stock has a market capitalization of $193.74 million and a P/E ratio of -3.83. IDEX Biometrics ASA has a 1-year low of $13.70 and a 1-year high of $31.62. The business has a 50-day moving average price of $16.20 and a two-hundred day moving average price of $21.92.

An institutional investor recently raised its position in IDEX Biometrics ASA stock. Morgan Stanley raised its stake in shares of IDEX Biometrics ASA (NASDAQ:IDBAGet Rating) by 1,539.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,639 shares of the company’s stock after buying an additional 1,539 shares during the quarter. Morgan Stanley’s holdings in IDEX Biometrics ASA were worth $31,000 at the end of the most recent reporting period. 0.01% of the stock is currently owned by institutional investors and hedge funds.

IDEX Biometrics ASA Company Profile (Get Rating)

IDEX Biometrics ASA engages in the design, development, and sale of fingerprint identification and authentication solutions in Europe, the Middle East, Africa, the Americas, and Asia. The company offers IDEX Biometrics for the biometrics smart card market, including biometric fingerprint sensors for use in dual interface, contactless only, and contact only smart cards; biometric fingerprint modules for contact based smart cards; and on-card enrollment solutions for remote in-person enrollment.

See Also

Get a free copy of the Zacks research report on IDEX Biometrics ASA (IDBA)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for IDEX Biometrics ASA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX Biometrics ASA and related companies with's FREE daily email newsletter.